Carisma Therapeutics, Inc. (CARM)

Carisma Therapeutics Revenue

In the year 2024, Carisma Therapeutics had annual revenue of $19.63M with 31.59% growth. Carisma Therapeutics had revenue of $3.65M in the quarter ending December 31, 2024, a decrease of -14.83%.

• Revenue (ttm): $19.63M
• Revenue Growth: +31.59%
• P/S Ratio: 0.41
• Revenue / Employee: $426,783
• Employees: 46
• Market Cap: 8.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	19.63M	4.71M	31.59%
Dec 31, 2023	14.92M	5.09M	51.71%
Dec 31, 2022	9.83M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.